Optimized Predictive Treatment In Medications for Unipolar Major Depression (OPTIMUM-D) — StellaPhase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(7 sites)
Canada
University of Calgary, Calgary, Alberta University of British Columbia, Vancouver, British Columbia Nova Scotia Health Authority, Halifax, Nova Scotia McMaster University, Hamilton, Ontario Queen's University, Kingston, Ontario University Health Network, Toronto, Ontario Centre for Addiction and Mental Health, Toronto, Ontario Age range
18 Years – 65 Years
Last updated February 2026